← Back to Search

Furosemide for Bladder Preparation in Pelvic Ultrasounds

Phase < 1
Waitlist Available
Led By Candice Jersey, D.O.
Research Sponsored by Connecticut Children's Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
Patients deemed to be critically ill (e.g. Mental status changes, signs of end organ damage, hypotension)
History of renal, genitourinary, or pelvic anomalies (e.g. Chronic kidney disease, anuria, vesicoureteral reflux, ureteral obstruction, urologic reconstructive surgery, suprapubic or pelvic surgery, indwelling urethral catheter, oophorectomy, bicornate uterus)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from time of intervention until final disposition, about 6 hours
Awards & highlights
All Individual Drugs Already Approved
Approved for 10 Other Conditions

Summary

This trial is testing if furosemide can help fill the bladder faster when given with IV fluids. It targets females aged 8 to 18 who need a pelvic ultrasound to check for ovarian torsion. Furosemide increases urine production, which helps fill the bladder quickly. Furosemide has been used to improve the quality of urinary bladder filling in CT urography examinations.

Who is the study for?
This trial is for girls aged 8-18 who need a pelvic ultrasound in the emergency department to check for ovarian torsion. They must be able to consent or have a guardian who can, and not be critically ill, pregnant, on diuretics recently, or have kidney/genitourinary issues.
What is being tested?
The study is testing if Furosemide helps fill the bladder quicker than just IV fluids for better ultrasound imaging. It's comparing these two methods in young females awaiting pelvic ultrasounds.
What are the potential side effects?
Furosemide may cause increased urination, dehydration risks, electrolyte imbalances (like low potassium), and possible allergic reactions if there's a sulfonamide medication allergy.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am critically ill with symptoms like confusion, organ damage, or low blood pressure.
Select...
I have had kidney, urinary, or pelvic problems or surgeries.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from time of intervention until final disposition, about 6 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and from time of intervention until final disposition, about 6 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The time from initiation of the intervention to the time that the bladder reaches large, ovoid shape on POCUS exam
Secondary study objectives
Number and nature of all reports of adverse events related to furosemide administration
The correlation between bladder volume as calculated on POCUS exam of a large, ovoid bladder and bladder volume as reported by bladder scanner

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: FurosemideExperimental Treatment1 Intervention
Participants will receive a 20mL/kg (max 1000mL) IV fluid bolus and a 0.1mg/kg (max 5mg) furosemide dose
Group II: IV fluidsPlacebo Group1 Intervention
Participants will receive a 20mL/kg (max 1000mL) IV fluid bolus and an IV fluid flush
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Furosemide
FDA approved

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for ovarian torsion involve surgical procedures like laparoscopy or laparotomy to untwist the ovary and restore blood flow. This is critical for patients because timely intervention can save the ovary, preserving its function and fertility. While furosemide, a diuretic, is not directly related to ovarian torsion treatment, both conditions highlight the importance of prompt medical attention to prevent long-term damage.
Conservative laparoscopic management of adnexal torsion based on a 17-year follow-up experience.

Find a Location

Who is running the clinical trial?

Connecticut Children's Medical CenterLead Sponsor
73 Previous Clinical Trials
26,582 Total Patients Enrolled
Candice Jersey, D.O.Principal InvestigatorConnecticut Children's Medical Center

Media Library

Furosemide Clinical Trial Eligibility Overview. Trial Name: NCT05098366 — Phase < 1
Ovarian Torsion Research Study Groups: IV fluids, Furosemide
Ovarian Torsion Clinical Trial 2023: Furosemide Highlights & Side Effects. Trial Name: NCT05098366 — Phase < 1
Furosemide 2023 Treatment Timeline for Medical Study. Trial Name: NCT05098366 — Phase < 1
~10 spots leftby Nov 2025